Arcinova appoints Kelly Rhys-Jones as Human Resources Director
Arcinova, the UK’s fastest growing multi-service Contract Development and Manufacturing Organisations (CDMOs), is delighted to welcome Kelly Rhys-Jones as Human Resources Director.
Kelly, who has over 20 years of human resources experience, joins Arcinova from Virgin Money where she spent three years working as Senior Human Resources Change Manager and Business Partner. Kelly has significant experience in all key areas of HR and organisational development including HR delivery transformation activities and complex business change and organisation development programs. Kelly holds a PG Diploma in Human Resource Management from Northumbria University.
Kelly’s appointment continues Arcinova’s strategy of strengthening the company’s management team following the appointment of Roger Kilburn as CEO in 2019. Kelly’s contribution will be pivotal to the continued growth of Arcinova, who since purchasing the site from Covance in 2016 has increased head count from 87 to 172 and plans to increase this further in 2021.
Kelly Rhys-Jones commented, "I am passionate about supporting colleagues to create great working environments where talented individuals and teams can realise their full potential. I’m delighted to be a part of the Arcinova team as we continue our growth journey, which will provide fantastic opportunities for individuals to grow with the business and develop new capabilities."
Roger Kilburn, CEO at Arcinova, commented, “We are enormously privileged to welcome Kelly to our team. Her unparalleled experience will be invaluable to us as we continue in the next leg of the already remarkable journey of Arcinova.”
Notes to editors
For further information, images and interview opportunities with Arcinova, please contact:
Sophie Read
+44 (0) 1665 608 884
About Arcinova
Arcinova is a Contract Development and Manufacturing Organisation that helps pharmaceutical and biotechnology companies across the globe develop life changing medicines. We employ a multidisciplinary approach to drug development by combining chemistry, biology and bioinformatics. All our services are delivered from our 15,000m2 facility in the North East of England.
We leverage our decades of experience as a key research and development centre to deliver high quality end-to-end solutions. Our mission is to deliver best-in-class technology services in the fields of contract research, development and small-scale manufacturing to overcome project challenges and increase efficiency.
For more information, visit www.arcinova.com